首页> 美国政府科技报告 >Department of the Army Supply Bulletin, Army Medical Department Supply Information, SB8-75-S10.
【24h】

Department of the Army Supply Bulletin, Army Medical Department Supply Information, SB8-75-S10.

机译:军队供应公告部,陆军医疗部供应信息,sB8-75-s10。

获取原文

摘要

Army National Guard medical units, organizations and installations are authorized and encouraged to receive medical supply support to include medical repair parts from the MEDCOM element with area support responsibility for the geographic area in which the unit/organization/installation to be supported is located. A delineation of Regional Medical Commands (RMCs) and the Medical Activity (MEDDAC) or Medical Center (MEDCEN) responsible for each is found in AR 59 (Area Support Responsibilities) and appropriate MEDCOM regulation. Such support is contingent upon establishment of a support agreement with the supporting MEDDAC or MEDCEN including a possible funding procedure. When supply support is to be provided to a unit or installation, the unit or installation will submit the required DA Form 1687 (Notice of Delegation of Authority Receipt for Supplies) through the United States Property and Fiscal Officer (USP&FO) to the supporting MEDDAC or MEDCEN. The USPFO will validate the form, ensuring that limitations concerning the materiel authorized to be requested are stated on the form. A Medical Corps Officer should sign DA Form 1687 for controlled drug supply support. The State Surgeon may be requested to perform this function and monitor the requesting of controlled substances by installations without an assigned physician. When controlled substances are requested, they may be transmitted directly from the Installation Medical Supply Activity (IMSA) at the MEDDAC or MEDCEN to the requesting unit/installation to facilitate security and accountability. In this case, bypassing the USPFO is authorized; however, receiving documentation must be provided to the USPFO in accordance with (IAW) each state/territory's SOP. Units/installations in close proximity to the supporting IMSA will be required to have an authorized individual personally receipt for the controlled substances.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号